monoclonal antibodies


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.
Related to monoclonal antibodies: Polyclonal antibodies

monoclonal antibodies

ANTIBODIES (immunoglobulins) produced by hybrid B lymphocyte tumours (myelomas). The type of antibodies produced depend on the selection of the B cell. These can be fused to cultured mouse, or even human, myeloma cells to form immortal tumours (hybridomas)-clones of cells that continue indefinitely to generate large quantities of the particular antibody produced by the B cell. The availability of quantities of almost any desired antibody has major diagnostic, therapeutic and research implications and monoclonal antibody production is one of the most important biotechnological advances of the century. Monoclonal antibodies can be made that will seek out and recognize cancers anywhere in the body, and this offers a number of intriguing possibilities for treatment. They are, however, less specific than had been initially thought, and can bind to molecules other than those intended. A serious accident occurred in a therapeutic trial in March 2206.

monoclonal antibodies

cloned (i.e. identical) antibodies

monoclonal

derived from a single cell; pertaining to a single clone.

monoclonal antibodies
identical immunoglobulin molecules formed by a single clone of plasma cells; may occur naturally in plasma cell myelomas or in vitro by the fusion of an antibody producing B lymphocyte with a non-antibody-producing myeloma B cell. The fused heterokaryon has the properties of immortality and production of a monoclonal antibody. For the most part, monoclonal antibodies are made in mouse systems.
monoclonal gammopathy
see monoclonal gammopathy.
References in periodicals archive ?
Table 124: Monoclonal Antibodies Market, Rheumatoid Arthritis,Global, Prescription Population, 2002- 2010 124
Table 125: Monoclonal Antibodies Market, Rheumatoid Arthritis,Global, Prescription Population, 2010- 2017 124
Table 126: Monoclonal Antibodies Market, Rheumatoid Arthritis,The US, Prescription Population, 2002- 2010 125
Table 127: Monoclonal Antibodies Market, Rheumatoid Arthritis,The US, Prescription Population, 2010- 2017 125
Table 128: Monoclonal Antibodies Market, Rheumatoid Arthritis, Europe, Prescription Population, 2002- 2010 126
Table 129: Monoclonal Antibodies Market, Rheumatoid Arthritis, Europe, Prescription Population, 2010- 2017 126
Table 130: Monoclonal Antibodies Market, Rheumatoid Arthritis, ROW, Prescription Population, 2002- 2010 127
Table 131: Monoclonal Antibodies Market, Rheumatoid Arthritis, ROW, Prescription Population, 2010- 2017 127
Table 132: Monoclonal Antibodies Market, Rheumatoid Arthritis, Global, Annual Cost of Therapy ($), 2002- 2010 128
Suspended & Discontinued Monoclonal Antibodies Pipeline by Phase, Indication, Company & Country
In 2008-09, 193 Monoclonal Antibodies were in Pipeline with a Majority Being Tested for Various Cancer Indications
The total market potential for monoclonal antibodies was estimated at $45.

Full browser ?